Long-term trial of bosentan monotherapy for pulmonary arterial hypertension in Japanese patients

Author： Sasayama Shigetake   Satoh Toru   Izumi Tohru   Yoshida Shunji   Kyotani Shingo   Tahara Nobuhiro  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.2, 2007-02, pp. : 395-400

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Bosentan in Chronic Thromboembolic Pulmonary Hypertension

By  

Respiration, Vol. 74, Iss. 3, 2006-05 ,pp. : 287-292

Karger

Access to resources Recommend Favorite

Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit?

By Clozel Martine  

Annals of Medicine, Vol. 35, Iss. 8, 2003-12 ,pp. : 605-613

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Long-Term Imatinib Therapy for Pulmonary Arterial Hypertension

By  

Respiration, Vol. 89, Iss. 6, 2015-06 ,pp. : 515-524

Karger

Access to resources Recommend Favorite

Long-Term Inhaled Nitric Oxide plus Dipyridamole for Pulmonary Arterial Hypertension

By  

Respiration, Vol. 72, Iss. 4, 2005-07 ,pp. : 419-422

Karger

Access to resources Recommend Favorite

Bosentan for treatment of pulmonary arterial hypertension (I)

By Antoniu Sabina A  

Therapy, Vol. 2, Iss. 6, 2005-11 ,pp. : 843-847

Future Medicine

Access to resources Recommend Favorite